Status:
COMPLETED
Diagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Toxoplasmosis
Toxoplasma Infections
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii and transmitted to humans through the consumption of raw or undercooked infected meat and / or by poorly washed vegetables. It can be t...
Detailed Description
Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii and transmitted to humans through the consumption of raw or undercooked infected meat and / or by poorly washed vegetables. It can be t...
Eligibility Criteria
Inclusion
- Patients over 15 years of age, for minor patients signature of both parents or parent authority representative
- Unknown HIV (questionnaire)
- Non-immunocompromised (questionnaire)
- Known serological status with toxoplasmosis
- Social Security Affiliate
- Informed Consent Signature
Exclusion
- Presence of known immunosuppression or immunosuppressive therapy (questionnaire).
- HIV-positive people will be excluded due to the immunosuppressive action of HIV
Key Trial Info
Start Date :
November 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 13 2023
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04825600
Start Date
November 17 2021
End Date
November 13 2023
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de NICE
Nice, France, 06003